Award

Ask AI about this notice

Summarise, research or assess it with AI

View Markdown

Share this notice

Send this contract to a colleague

Analgesics & Anaesthetics, Musculoskeletal & Joint Disease Generic Medicine

The Common Services Agency (more commonly known as NHS National Services Scotland) ("the Authority")

This public procurement record has 2 releases in its history.

Award

03 Feb 2020 at 00:00

OJEU - F3 - Contract Award Notice
Tender

23 Sep 2019 at 01:00

OJEU - F2 - Contract Notice
Summary of the contracting process

The procurement process for the "Analgesics & Anaesthetics, Musculoskeletal & Joint Disease Generic Medicine" contract is being conducted by the Common Services Agency, commonly known as NHS National Services Scotland. This procurement falls under the health sector and is based in Edinburgh. The process is at the planning stage, with a deadline for submissions set for 25th October 2019. The authority is employing an open procurement method, which allows any interested supplier to bid for this framework agreement.

This tender presents substantial opportunities for growth, particularly for businesses operating within the pharmaceutical and medical supply sectors. Notably, companies that can supply generic medicines or have expertise in analgesics and anaesthetics will find this tender appealing. Businesses must be able to demonstrate compliance with pharmaceutical regulations, including possessing valid marketing authorisations and quality certifications, making this an ideal opportunity for large-scale pharmaceutical manufacturers or distributors seeking to establish long-term contracts with NHS entities.

How relevant is this notice?

Notice Information

Notice Title

Analgesics & Anaesthetics, Musculoskeletal & Joint Disease Generic Medicine

Notice Description

Supply of Analgesics & Anaesthetics, Musculoskeletal & Joint Disease Generic Medicines to NHS Scotland.

Lot Information

Lot 1 Baclofen Intrathecal Injections

The supply of Baclofen Intrathecal Injections to NHS Scotland in a range of presentations. The Authority has awarded this lot as a single supplier framework.

Renewal: This framework includes the option(s) to extend for up to a total period of twenty-four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.

Lot 2 Oxycodone Injections

The Supply of Oxycodone Injections to NHS Scotland in a range of presentations. The Authority has awarded this lot as a single supplier framework.

Renewal: This framework includes the option(s) to extend for up to a total period of twenty-four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.

Lot 3 Levobupivacaine (As Hydrochloride) Sterile Wrapped Ampoules For Injection

The Supply of Levobupivacaine (As Hydrochloride) Sterile Wrapped Ampoules For Injection to NHS Scotland in a range of presentations. The Authority has awarded this lot as a single supplier framework.

Renewal: This framework includes the option(s) to extend for up to a total period of twenty-four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.

Lot 4 Oxycodone Hydrochloride Prolonged Release Tablets

The Supply of Oxycodone Hydrochloride Prolonged Release Tablets to NHS Scotland in a range of presentations. The Authority has awarded each product line within this lot as a multi-supplier unranked framework agreement to a maximum of six (6) Framework Participants.

Renewal: This framework includes the option(s) to extend for up to a total period of twenty-four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.

Lot 5 Buprenorphine Patches

The supply of Buprenorphine Patches to NHS Scotland in a range of presentations. The Authority has awarded each product line within this lot as a multi-supplier unranked framework agreement to a maximum of six (6) Framework Participants.

Renewal: This framework includes the option(s) to extend for up to a total period of twenty-four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.

Lot 6 Fentanyl Tablets (Sublingual)

The Supply of Fentanyl Tablets (Sublingual) to NHS Scotland in a range of presentations. The Authority has awarded each product line within this lot as a multi-supplier unranked framework agreement to a maximum of six (6) Framework Participants.

Renewal: This framework includes the option(s) to extend for up to a total period of twenty-four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.

Lot 7 Fentanyl Sf Tablet (Buccal)

Supply of Fentanyl Sf Tablets(Buccal) to NHS Scotland in a range of presentations. The Authority has awarded each product line within this lot as a multi-supplier unranked framework agreement to a maximum of six (6) Framework Participants.

Renewal: This framework includes the option(s) to extend for up to a total period of twenty-four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.

Lot 8 - Fentanyl Transdermal Patch

Supply of Fentanyl Transdermal Patch to NHS Scotland in a range of presentations. The Authority has awarded each product line within this lot as a multi-supplier unranked framework agreement to a maximum of six (6) Framework Participants.

Renewal: This framework includes the option(s) to extend for up to a total period of twenty-four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.

Lot 9 - Hydromorphone

Supply of Hydromorphone Capsules and Injection to NHS Scotland in a range of presentations. The Authority has awarded each product line within this lot as a multi-supplier unranked framework agreement to a maximum of six (6) Framework Participants.

Renewal: This framework includes the option(s) to extend for up to a total period of twenty-four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.

Lot 10 - Lidocaine Chlorhexidine Gel

Supply of Lidocaine Chlorhexidine Gel to NHS Scotland in a range of presentations. The Authority has awarded each product line within this lot as a multi-supplier unranked framework agreement to a maximum of six (6) Framework Participants.

Renewal: This framework includes the option(s) to extend for up to a total period of twenty-four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.

Lot 11 - Morphine Sulfate Modified-Release capsule (12Hr)

Supply of Morphine Sulfate Modified-Release capsule (12hr) to NHS Scotland in a range of presentations. The Authority has awarded each product line within this lot as a multi-supplier unranked framework agreement to a maximum of six (6) Framework Participants.

Renewal: This framework includes the option(s) to extend for up to a total period of twenty-four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.

Lot 13 - Morphine Sulfate Modified-Release Tablet

The Supply of Morphine Sulfate Modified-Release Tablet to NHS Scotland in a range of presentations. The Authority has awarded each product line within this lot as a multi-supplier unranked framework agreement to a maximum of six (6) Framework Participants.

Renewal: This framework includes the option(s) to extend for up to a total period of twenty-four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.

Lot 12 - Morphine Sulfate Modified-Release capsule (24Hr)

The Supply of Morphine Sulfate Modified-Release capsule (24Hr) to NHS Scotland in a range of presentations. The Authority has awarded each product line within this lot as a multi-supplier unranked framework agreement to a maximum of six (6) Framework Participants.

Renewal: This framework includes the option(s) to extend for up to a total period of twenty-four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.

Lot 14 - Oxycodone Hydrochloride Capsules

The Supply of Oxycodone Hydrochloride Capsules to NHS Scotland in a range of presentations. The Authority has awarded each product line within this lot as a multi-supplier unranked framework agreement to a maximum of six (6) Framework Participants.

Renewal: This framework includes the option(s) to extend for up to a total period of twenty-four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.

Lot 15 - Propofol Injection

The Supply of Propofol Injection to NHS Scotland in a range of presentations. The Authority has awarded each product line within this lot as a multi-supplier unranked framework agreement to a maximum of six (6) Framework Participants.

Renewal: This framework includes the option(s) to extend for up to a total period of twenty-four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.

Lot 16 - Tramadol Hydrochloride Modified Release Tablets

The Supply of Tramadol Hydrochloride Modified Release Tablets to NHS Scotland in a range of presentations. The Authority has awarded each product line within this lot as a multi-supplier unranked framework agreement to a maximum of six (6) Framework Participants.

Renewal: This framework includes the option(s) to extend for up to a total period of twenty-four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.

Lot 17 - Oxycodone Oral Solution

The Supply of Oxycodone Oral Solution to NHS Scotland in a range of presentations. The Authority has awarded each product line within this lot as a multi-supplier unranked framework agreement to a maximum of six (6) Framework Participants.

Renewal: This framework includes the option(s) to extend for up to a total period of twenty-four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.

Lot 18 - All Other Analgesics & Anaesthetics, Musculoskeletal & Joint Disease Generic Medicines

Supply of all other Analgesics & Anaesthetics, Musculoskeletal & Joint Disease Generic Medicine in a range of presentations. The Authority has awarded each line within this Lot as a single Framework.

Renewal: This framework includes the option(s) to extend for up to a total period of twenty-four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.

Notice Details

Publication & Lifecycle

Open Contracting ID
ocds-r6ebe6-0000595876
Publication Source
Public Contracts Scotland
Latest Notice
https://www.publiccontractsscotland.gov.uk/search/show/search_view.aspx?ID=FEB379670
Current Stage
Award
All Stages
Tender, Award

Procurement Classification

Notice Type
OJEU - F3 - Contract Award Notice
Procurement Type
Framework
Procurement Category
Goods
Procurement Method
Open
Procurement Method Details
Open procedure
Tender Suitability
Not specified
Awardee Scale
Large

Common Procurement Vocabulary (CPV)

CPV Divisions

33 - Medical equipments, pharmaceuticals and personal care products

CPV Codes

33600000 - Pharmaceutical products

Notice Value(s)

Tender Value
£38,278,416 £10M-£100M
Lots Value
£38,278,415 £10M-£100M
Awards Value
Not specified
Contracts Value
£28,229,605 £10M-£100M

Notice Dates

Publication Date
3 Feb 20206 years ago
Submission Deadline
25 Oct 2019Expired
Future Notice Date
Not specified
Award Date
20 Dec 20196 years ago
Contract Period
Not specified - Not specified
Recurrence
Not specified

Notice Status

Tender Status
Complete
Lots Status
Complete
Awards Status
Not Specified
Contracts Status
Active

Buyer & Supplier

Contracting Authority (Buyer)

Main Buyer
The Common Services Agency (more commonly known as NHS National Services Scotland) ("the Authority")
Contact Name
Available with D3 Tenders Premium →
Contact Email
Available with D3 Tenders Premium →
Contact Phone
Available with D3 Tenders Premium →

Buyer Location

Locality
EDINBURGH
Postcode
EH12 9EB
Postcode Area
Edinburgh
Country
Scotland
Major Region (ITL 1)
TLM Scotland
Basic Region (ITL 2)
TLM1 East Central Scotland
Small Region (ITL 3)
TLM13 City of Edinburgh
Delivery Location
TLM Scotland
Local Authority
City of Edinburgh
Electoral Ward
Drum Brae/Gyle
Westminster Constituency
Edinburgh South West

Supplier Information

Number of Suppliers
40
Supplier Names

Accord Healthcare Ltd

Aguettant Ltd

Altan Pharma

Aspen Pharma Ireland Ltd

B. Braun Medical Ltd

Bowmed Ibisqus Limited

Chiesi Limited

Clinimed Limited

Consilient Health Ltd

Crescent Pharma Limited

Focus Pharmaceuticals Ltd

Fresenius Kabi Limited

Fresenius Kabi Ltd

GlaxoSmithKline

Grunenthal Ltd

Intrapharm Laboratories Ltd

Janssen-Cilag Ltd

Kent Pharmaceuticals Ltd

Kyowa Kirin

Martindale Pharma

Medreich PLC

Mercury Pharma Group

Morningside Pharmaceuticals Limited

Napp Pharmaceuticals

Optimum Medical Solutions

Pfizer Ltd

Piramal CC

Qdem Pharmaceuticals

Ranbaxy (UK) Ltd

Sandoz Ltd

Selective Supplies Ltd

South Devon Healthcare NHS Foundations Trust t/a Torbay PMU

Syri Limited T/A Thame Laboratories

Teva UK Limited

Thornton & Ross

Typharm Ltd

Vidant Pharma Ltd

Wockhardt UK Limited

Zentiva Pharma UK Ltd

hameln pharmaceuticals ltd

Further Information

Notice Documents

Open Contracting Data Standard (OCDS)

View full OCDS Record for this contracting process

JSON Markdown

The Open Contracting Data Standard (OCDS) is a framework designed to increase transparency and access to public procurement data in the public sector. It is widely used by governments and organisations worldwide to report on procurement processes and contracts.

Loading OCDS record...